Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Denosumab (Xgeva)
Start Date
January 1, 2014
Primary Completion Date
December 31, 2016
Completion Date
December 31, 2017
Last Updated
January 30, 2018
NCT06014619
NCT03525392
NCT01445080
NCT00036738
NCT00003145
NCT02204761
Lead Sponsor
Peking University People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions